Intra-Cellular Therapies Inc (NASDAQ:ITCI)

43.04
Delayed Data
As of Jan 14
 +2.07 / +5.05%
Today’s Change
28.40
Today|||52-Week Range
55.20
-17.77%
Year-to-Date

Today’s Trading

Previous close40.97
Today’s open40.59
Day’s range40.33 - 43.14
Volume44,870
Average volume (3 months)780,972
Market cap$4.0B
Data as of 4:00pm ET, 01/14/2022

Growth & Valuation

Earnings growth (last year)-20.52%
Earnings growth (this year)-7.01%
Earnings growth (next 5 years)+2.50%
Revenue growth (last year)+37,537.11%
P/E ratioNM
Price/Sales98.08
Price/Book5.27

Competitors

----
APLSApellis Pharmaceutic...-0.47-1.15%
ALKSAlkermes Plc+0.38+1.53%
----
Data as of 4:00pm ET, 01/14/2022

Financials

Next reporting dateMarch 2, 2022
EPS forecast (this quarter)-$1.01
Annual revenue (last year)$22.8M
Annual profit (last year)-$227.0M
Net profit margin-995.07%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts